H Yki-Järvinen - Concepedia

Author

H Yki-Järvinen

Also Known As

H Yki-Jarvinen, H Yki-Järvinen, H. YKI‐JÄRVINEN, H. Yki-Jarvinen, H. Yki-Järvinen, H. Yki-Järvinen, H. Yki‐Jarvinen, H. Yki‐Järvinen, Hannele Yki-Järvinen

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Helsinki University Hospital Minerva Foundation Helsinki Institute of Physics Joslin Diabetes Center

About

H Yki-Järvinen is an author at University of Helsinki specializing in medicine, metabolic syndrome, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	16	1.1K
2	Health Sciences	11	12	545
3	Applied Physiology	3	3	240
4	Biochemistry	3	3	92
5	Biomolecular Engineering	1	1	47

H Yki-Järvinen

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Michael Stümvoll, Asimina Mitrakou, Walkyria de Paula Pimenta, Diabetes Care	2000	1K
Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study H Yki-Järvinen, Mirja Tiikkainen, Markku Vähätalo, Diabetologia Metabolic SyndromeDiabetes ManagementInsulin GlargineInsulin ManagementDiabetes	2006	435
Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. L. Ryysy, A. Häkkinen, Takashi Goto, Diabetes	2000	434
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes Tina Vilsbøll, Julio Rosenstock, H Yki-Järvinen, Diabetes Obesity and Metabolism	2009	303
Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Mary‐Elizabeth Patti, A Virkamäki, Edwin J. Landaker, Diabetes	1999	251
Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivo Robert Bergholm, Sari Mäkimattila, Miia Valkonen, Atherosclerosis Physical ActivityExerciseExercise PhysiologyPhysiologyEndothelium-dependent Vasodilatation	1999	181
Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12‐month trial including 6‐month extension H Yki-Järvinen, Richard M. Bergenstal, Geremia B. Bolli, Diabetes Obesity and Metabolism	2015	131
Insulin-induced hexokinase II expression is reduced in obesity and NIDDM. M. Pendergrass, John J. Koval, C Vogt, Diabetes	1998	118
In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Satu Vehkavaara, Anneli Seppälä‐Lindroos, Jukka Westerbacka, Diabetes Care	1999	107
Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative. Juhani Knuuti, H Yki-Järvinen, L M Voipio-Pulkki, PubMed	1994	96

Page 1